Therapy News and Research

RSS

DOST imaging may help predict tumor response before starting treatment

A Dartmouth study suggests that it may be possible to use Diffuse Optical Spectroscopic Tomographic imaging (DOST) to predict which patients will best respond to chemotherapy used to shrink breast cancer tumors before surgery. These findings could eliminate delays in effective early treatment for tumors unlikely to respond to neoadjuvant chemotherapy (NAC).

27 Oct 2014

Researchers to explore new treatment strategies using blood plasma from Ebola survivors

The University of Liverpool is part of an international research team that will assess whether the blood or plasma of Ebola survivors can be used to treat Ebola patients in West Africa.

27 Oct 2014

Economic impact of hypoglycaemia: an interview with Dr Klaus Henning Jensen

Hypoglycaemia is the term used to describe a lower than normal blood sugar level. There are a number of things that actually need to be formally defined in order for a hypoglycaemic episode to be diagnosed.

26 Oct 2014

OTSC placement therapy is safe, effective for closure of gastrointestinal defects

An international multicenter study reports that over-the-scope clip (OTSC) placement is a safe and effective therapy for the closure of gastrointestinal (GI) defects, which includes anastomotic leaks, fistulae and perforations.

26 Oct 2014

Rates of type 1 diabetes increase significantly among non-Hispanic white youth

The rate of non-Hispanic white youth diagnosed with type 1 diabetes increased significantly from 2002 to 2009 in all but the youngest age group of children, according to a new study published today in the journal Diabetes.

25 Oct 2014

Study reveals subtypes, potential diagnostic and treatment clues for papillary thyroid carcinomas

A comprehensive analysis of the genomes of nearly 500 papillary thyroid carcinomas (PTC) – the most common form of thyroid cancer – has provided new insights into the roles of frequently mutated cancer genes and other genomic alterations that drive disease development.

25 Oct 2014

UC San Diego Sanford Stem Cell Clinical Center named new 'alpha clinic'

In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new "alpha clinics" by the California Institute for Regenerative Medicine, the state's stem cell agency.

25 Oct 2014

Researchers reveal how particular melanoma cells help tumors resist drugs

UNC School of Medicine researchers have pinpointed a set of intriguing characteristics in a previously unknown subpopulation of melanoma cancer cells in blood vessels of tumors. These cells, which mimic non-cancerous endothelial cells that normally populate blood vessels in tumors, could provide researchers with another target for cancer therapies.

25 Oct 2014

BRI receives FDA permission to conduct study of Antineoplastons A10 and AS2-1 in DIPG patients

Burzynski Research Institute, Inc. announced today that the U.S. Food and Drug Administration has given the company permission to conduct an open-label study of Antineoplastons A10 and AS2-1 in patients > 3 months of age with a diffuse intrinsic brainstem glioma (DIPG).

25 Oct 2014

State highlights: Health care takes center stage in debates in Maine, Arizona, Missouri

The three candidates for governor clashed Tuesday in their final debate, highlighting their differences on a wide range of issues, including health care and welfare. Partisan sparks flew early and often between Republican Gov. Paul LePage and Democratic U.S. Rep. Mike Michaud, who are running in a dead heat in the race, far ahead of independent Eliot Cutler, two weeks before Maine residents go to the polls (10/21).

24 Oct 2014

Study finds that beetroot can improve athletic performance, benefit heart failure patients

Football teams are claiming it improves their athletic performance, and according to new research from Kansas State University, it also benefits heart failure patients. The special ingredient: beetroot.

24 Oct 2014

electroCore’s gammaCore device effective for treating migraines, shows trial results

Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore’s hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.

24 Oct 2014

The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

Hokkaido University and Hitachi, Ltd. have announced that the approval under Japan’s Pharmaceutical Affairs Law has been granted to Hitachi for the manufacture and sales of the PROBEAT-RT, a proton beam therapy treatment system combining spot scanning irradiation and Real-time Tumor-tracking Radiation Therapy.

23 Oct 2014

HAMILTON-C1 provides optimal ventilation therapy for neonates

The high‐performance capabilities of the HAMILTON‐C1 with the new Neonatal option include lung protective strategies and adaptive ventilation modes to ensure that each baby receives treatment tailored to its specific needs. Requiring only a minimum of space, the HAMILTON‐C1 combines high reliability, ease of use and maximum mobility with optimal performance for your most fragile patients.

23 Oct 2014

Study: Music therapy improves self-esteem, reduces depression in children

Researchers at Queen's University Belfast have discovered that music therapy reduces depression in children and adolescents with behavioural and emotional problems.

23 Oct 2014

Afatinib active against NSCLC nervous system metastases

Heavily pretreated patients with epidermal growth factor receptor-mutated non-small-cell lung cancer and central nervous system metastases may benefit from treatment with afatinib, say German researchers.

22 Oct 2014

HRQoL goals may improve outcome in PAH

Health-related quality of life before and during treatment for pulmonary arterial hypertension is significantly associated with survival, Brazilian researchers report.

22 Oct 2014

‘Neuroprotective’ effects of smoking disputed

The apparent neuroprotective effect of smoking may simply be because ease of quitting smoking is a marker of prodromal Parkinson’s disease, say researchers.

22 Oct 2014

Team-based care shown to be most effective way to control hypertension

Patients diagnosed with high blood pressure are given better control of their condition from a physician-pharmacist collaborative intervention than physician management alone, according to new research.

22 Oct 2014

Regulus Therapeutics demonstrates human proof-of-concept with microRNA therapeutic

Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 (“miR-122”), for the treatment of hepatitis C virus infection (“HCV”).

22 Oct 2014

Therapy News and Research

DOST imaging may help predict tumor response before starting treatment

Researchers to explore new treatment strategies using blood plasma from Ebola survivors

Economic impact of hypoglycaemia: an interview with Dr Klaus Henning Jensen

OTSC placement therapy is safe, effective for closure of gastrointestinal defects

Rates of type 1 diabetes increase significantly among non-Hispanic white youth

Study reveals subtypes, potential diagnostic and treatment clues for papillary thyroid carcinomas

UC San Diego Sanford Stem Cell Clinical Center named new 'alpha clinic'

Researchers reveal how particular melanoma cells help tumors resist drugs

BRI receives FDA permission to conduct study of Antineoplastons A10 and AS2-1 in DIPG patients

State highlights: Health care takes center stage in debates in Maine, Arizona, Missouri

Study finds that beetroot can improve athletic performance, benefit heart failure patients

electroCore’s gammaCore device effective for treating migraines, shows trial results

The PROBEAT-RT Proton Beam Therapy System incorporating real-time tumor-tracking is approved in Japan

HAMILTON-C1 provides optimal ventilation therapy for neonates

Study: Music therapy improves self-esteem, reduces depression in children

Afatinib active against NSCLC nervous system metastases

HRQoL goals may improve outcome in PAH

‘Neuroprotective’ effects of smoking disputed

Team-based care shown to be most effective way to control hypertension

Regulus Therapeutics demonstrates human proof-of-concept with microRNA therapeutic

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News